论文信息 - Carfilzomib, Pomalidomide and Dexamethasone (KPd) in Patients with Multiple Myeloma Refractory to Bortezomib and Lenalidomide. the EMN011 Trial - 字舞流文

Carfilzomib, Pomalidomide and Dexamethasone (KPd) in Patients with Multiple Myeloma Refractory to Bortezomib and Lenalidomide. the EMN011 Trial

K. Nasserinejad | P. Sonneveld | M. Boccadoro | S. Croockewit | M. Minnema | A. Broyl | F. Patriarca | P. Corradini | M. Cavo | S. Zweegman | J. Droogendijk | K. Iskander | L. Pour | KaLung Wu | Bruno Costa | R. Troia | K. Wu | Bruno M. Costa